These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38745261)

  • 1. Endotyping in ARDS: one step forward in precision medicine.
    Côté A; Lee CH; Metwaly SM; Doig CJ; Andonegui G; Yipp BG; Parhar KKS; Winston BW
    Eur J Med Res; 2024 May; 29(1):284. PubMed ID: 38745261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapidly improving ARDS differs clinically and biologically from persistent ARDS.
    Valda Toro PL; Willmore A; Wu NE; Delucchi KL; Jauregui A; Sinha P; Liu KD; Hendrickson CM; Sarma A; Neyton LPA; Leligdowicz A; Langelier CR; Zhuo H; Jones C; Kangelaris KN; Gomez AD; Matthay MA; Calfee CS
    Crit Care; 2024 Apr; 28(1):132. PubMed ID: 38649920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.
    Calfee CS; Delucchi K; Parsons PE; Thompson BT; Ware LB; Matthay MA;
    Lancet Respir Med; 2014 Aug; 2(8):611-20. PubMed ID: 24853585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxygenation Saturation Index Predicts Clinical Outcomes in ARDS.
    DesPrez K; McNeil JB; Wang C; Bastarache JA; Shaver CM; Ware LB
    Chest; 2017 Dec; 152(6):1151-1158. PubMed ID: 28823812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time.
    Meduri GU; Headley S; Kohler G; Stentz F; Tolley E; Umberger R; Leeper K
    Chest; 1995 Apr; 107(4):1062-73. PubMed ID: 7705118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Establishment and verification of LIPS score combined with APACHE II score and oxygenation index to predict the occurrence model of ARDS].
    Zhao F; Shen Z; Yang C; Cong Z; Zhang H; Zhu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Oct; 34(10):1048-1054. PubMed ID: 36473562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of distinct clinical phenotypes of acute respiratory distress syndrome with differential responses to treatment.
    Liu X; Jiang Y; Jia X; Ma X; Han C; Guo N; Peng Y; Liu H; Ju Y; Luo X; Li X; Bu Y; Zhang J; Liu Y; Gao Y; Zhao M; Wang H; Luo L; Yu K; Wang C
    Crit Care; 2021 Aug; 25(1):320. PubMed ID: 34461969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biological markers for predicting ARDS and outcome in septic patients.
    Villar J; Herrán-Monge R; González-Higueras E; Prieto-González M; Ambrós A; Rodríguez-Pérez A; Muriel-Bombín A; Solano R; Cuenca-Rubio C; Vidal A; Flores C; González-Martín JM; García-Laorden MI;
    Sci Rep; 2021 Nov; 11(1):22702. PubMed ID: 34811434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The precision medicine for the treatment of acute respiratory distress syndrome is based on identification of phenotypes].
    Liu YN; Ma XC
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(15):1253-1257. PubMed ID: 38637165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.
    Sinha P; Furfaro D; Cummings MJ; Abrams D; Delucchi K; Maddali MV; He J; Thompson A; Murn M; Fountain J; Rosen A; Robbins-Juarez SY; Adan MA; Satish T; Madhavan M; Gupta A; Lyashchenko AK; Agerstrand C; Yip NH; Burkart KM; Beitler JR; Baldwin MR; Calfee CS; Brodie D; O'Donnell MR
    Am J Respir Crit Care Med; 2021 Dec; 204(11):1274-1285. PubMed ID: 34543591
    [No Abstract]   [Full Text] [Related]  

  • 12. The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis.
    Mikkelsen ME; Shah CV; Meyer NJ; Gaieski DF; Lyon S; Miltiades AN; Goyal M; Fuchs BD; Bellamy SL; Christie JD
    Shock; 2013 Nov; 40(5):375-81. PubMed ID: 23903852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.
    Sinha P; Calfee CS; Cherian S; Brealey D; Cutler S; King C; Killick C; Richards O; Cheema Y; Bailey C; Reddy K; Delucchi KL; Shankar-Hari M; Gordon AC; Shyamsundar M; O'Kane CM; McAuley DF; Szakmany T
    Lancet Respir Med; 2020 Dec; 8(12):1209-1218. PubMed ID: 32861275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of results of therapy of acute respiratory failure : changes over a period of two decades].
    Briegel I; Dolch M; Irlbeck M; Hauer D; Kaufmann I; Schelling G
    Anaesthesist; 2013 Apr; 62(4):261-70. PubMed ID: 23558717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology-associated heterogeneity in acute respiratory distress syndrome: a retrospective cohort study.
    Ruan SY; Huang CT; Chien YC; Huang CK; Chien JY; Kuo LC; Kuo PH; Ku SC; Wu HD
    BMC Pulm Med; 2021 May; 21(1):183. PubMed ID: 34059024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of a biomarker and clinical prediction model for hospital mortality in acute respiratory distress syndrome.
    Zhao Z; Wickersham N; Kangelaris KN; May AK; Bernard GR; Matthay MA; Calfee CS; Koyama T; Ware LB
    Intensive Care Med; 2017 Aug; 43(8):1123-1131. PubMed ID: 28593401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the new acute respiratory distress syndrome (ARDS) criteria on Berlin criteria ARDS patients: a multicenter cohort study.
    Zhao L; Su F; Zhang N; Wu H; Shen Y; Liu H; Li X; Li Y; Xie K
    BMC Med; 2023 Nov; 21(1):456. PubMed ID: 37996902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials.
    Sinha P; Delucchi KL; McAuley DF; O'Kane CM; Matthay MA; Calfee CS
    Lancet Respir Med; 2020 Mar; 8(3):247-257. PubMed ID: 31948926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
    Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
    Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.